Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
1999 1
2000 1
2001 1
2002 5
2003 4
2004 3
2005 2
2006 4
2007 5
2008 5
2009 2
2011 1
2012 4
2013 1
2014 2
2015 3
2016 5
2017 6
2018 5
2020 5
2021 6
2022 6
2023 9
2024 9
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.
Mall MA, Brugha R, Gartner S, Legg J, Moeller A, Mondejar-Lopez P, Prais D, Pressler T, Ratjen F, Reix P, Robinson PD, Selvadurai H, Stehling F, Ahluwalia N, Arteaga-Solis E, Bruinsma BG, Jennings M, Moskowitz SM, Noel S, Tian S, Weinstock TG, Wu P, Wainwright CE, Davies JC. Mall MA, et al. Among authors: prais d. Am J Respir Crit Care Med. 2022 Dec 1;206(11):1361-1369. doi: 10.1164/rccm.202202-0392OC. Am J Respir Crit Care Med. 2022. PMID: 35816621 Free PMC article. Clinical Trial.
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Keating C, Yonker LM, Vermeulen F, Prais D, Linnemann RW, Trimble A, Kotsimbos T, Mermis J, Braun AT, O'Carroll M, Sutharsan S, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Floreth T, Michelson P, Sosnay PR, Nair N, Zahigian R, Martin H, Ahluwalia N, Lam A, Horsley A; VX20-121-102 Study Group; VX20-121-103 Study Group. Keating C, et al. Among authors: prais d. Lancet Respir Med. 2025 Mar;13(3):256-271. doi: 10.1016/S2213-2600(24)00411-9. Epub 2025 Jan 2. Lancet Respir Med. 2025. PMID: 39756424 Free PMC article. Clinical Trial.
Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study.
Domany KA, Mandelberg A, Burrack N, Golan-Tripto I, Masarweh K, Gur M, Rochman M, Be'er M, Prais D, Mor M, Opek MW, Nasrallah E, Megged O, Shatzman Steuerman R, Stein M, Steinberg Z, Shehadeh S, Glatman-Freedman A, Tasher D. Domany KA, et al. Among authors: prais d. Pediatr Pulmonol. 2025 Mar;60(3):e71022. doi: 10.1002/ppul.71022. Pediatr Pulmonol. 2025. PMID: 40042149 Free PMC article.
COVID-19 in advanced Duchenne/Becker muscular dystrophy patients.
Levine H, Prais D, Aharoni S, Nevo Y, Katz J, Rahmani E, Goldberg L, Scheuerman O. Levine H, et al. Among authors: prais d. Neuromuscul Disord. 2021 Jul;31(7):607-611. doi: 10.1016/j.nmd.2021.03.011. Epub 2021 Apr 6. Neuromuscul Disord. 2021. PMID: 34053847 Free PMC article.
Acquired tracheoesophageal fistula following rubber toy ingestion.
Bar-On O, Almog A, Peysakhovich Y, Kravarusic D, Shouval D, Stafler P, Prais D. Bar-On O, et al. Among authors: prais d. Pediatr Pulmonol. 2024 Dec;59(12):3757-3759. doi: 10.1002/ppul.27248. Epub 2024 Sep 16. Pediatr Pulmonol. 2024. PMID: 39282848
101 results